Stockscreener 앱 받기
16.69
0.42%
-0.07
시간 외 거래:
16.69
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Tandem Diabetes Care Q1 earnings call highlights - MSN
Tandem insulin pumps cleared in EU for expanded indications - MSN
TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up - Eastern Progress
Tandem Diabetes Care Inc (TNDM) Shares Surge 5.1% -- What GF Sco - GuruFocus
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Why Insulet thinks its fully closed loop system will stand apart from rivals - MedTech Dive
BofA Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $25 - Moomoo
TNDM: Momentum builds with pharmacy transition, Mobi Tubeless launch, and international expansion - TradingView
Tandem Diabetes Care Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
3 takeaways from ADA - MedTech Dive
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy - BioSpace
How The Investment Story For Tandem Diabetes Care (TNDM) Is Evolving Without New Analyst Targets - Yahoo Finance
Wall Street analysts see a 56.2% upside in Tandem Diabetes Care (TNDM): Can the stock really move this high? - MSN
Technical Reactions to TNDM Trends in Macro Strategies - Stock Traders Daily
Tandem Diabetes (TNDM) Secures CE Mark for Expanded Use of Insul - GuruFocus
Tandem Diabetes’ Insulin Pumps Win EU Nods for T2D, T1D in Pregnancy - Medical Product Outsourcing
Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High? - Yahoo Finance
Tandem Diabetes receives CE mark for expanded insulin pump uses By Investing.com - Investing.com Nigeria
Tandem Diabetes receives CE mark for expanded insulin pump uses - Investing.com
[Form 4] TANDEM DIABETES CARE INC Insider Trading Activity - Stock Titan
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs. - MedTech Dive
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now - Yahoo Finance
Tandem: Upgrading To Hold On A High-Stakes Pivot Story - Seeking Alpha
Tandem Diabetes Valuation: Is 1.1x Sales a Buy? - Yahoo Finance
Wells Fargo Upgrade Highlights Tandem Diabetes Care Pharmacy And Pump Shift - Yahoo Finance
Tandem Diabetes Care Hits Day High with 11.16% Surge in Stock Price - Markets Mojo
Tandem Diabetes Care (TNDM) CEO receives 191,103 RSUs under 2023 incentive plan - Stock Titan
Tandem Diabetes Care (TNDM) EVP awarded 29,136 RSUs under 2023 incentive plan - Stock Titan
Tandem Diabetes (TNDM) CFO receives 62,657 restricted stock unit award - Stock Titan
29,136 RSUs granted to Tandem Diabetes Care (TNDM) chief operating officer - Stock Titan
Tandem Diabetes Care (TNDM) EVP receives 29,136 RSU equity award - Stock Titan
Tandem Diabetes Care (TNDM) CTO awarded 26,003 RSUs under 2023 incentive plan - Stock Titan
Tandem Diabetes Care (TNDM) awards 29,136 RSUs to EVP & Chief Legal Officer - Stock Titan
TNDM Stock: What to Know About Tandem's 2026 Reset - TradingView
Why Is Tandem Diabetes (TNDM) Stock Soaring Today - Yahoo Finance
Why is Tandem Diabetes Care stock surging today? By Investing.com - Investing.com Canada
TNDM Upgraded by Wells Fargo -- Price Target Raised to $27 - GuruFocus
Tandem Diabetes (TNDM) Receives Upgrade from Wells Fargo - GuruFocus
Wells Fargo Upgrades Tandem Diabetes Care to Overweight From Equalweight, Adjusts Price Target to $27 From $21 - marketscreener.com
Tandem Diabetes Care Hits Day High with 12.82% Surge in Stock Price - Markets Mojo
Wells Fargo upgrades Tandem Diabetes stock rating on pharmacy outlook By Investing.com - Investing.com Canada
TNDM stock down following Q1 earnings & revenue beat, gross margin up - MSN
What Does Tandem Diabetes Care's Upsized Convertible Note Offering Mean for Investors - Kavout
Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $17 - Moomoo
TNDM Maintained by Citigroup -- Price Target Lowered to $17 - GuruFocus
Tandem Diabetes Care Inc (TNDM) Shares Surge 12.9% -- What GF Sc - GuruFocus
Q1 2025 Tandem Diabetes Care Inc Earnings Call Transcript - GuruFocus
1.21%
1.43%
자본화:
|
볼륨(24시간):